Results 21 to 30 of about 114,754,979 (236)

Botulinum Toxin Type a in Cervical Dystonia

International Journal of Immunopathology and Pharmacology, 2012
Cervical dystonia is a syndrome characterized by anomalous postures and unintentional repetitive movements of the head and the neck. Aim of this study is to show the effectiveness of the combined treatment botulinum toxin-FKT through the use of a recent methodic of investigation, myoton, and of the classical clinical evaluations, such as Tsui and VAS ...
Marvulli R., Ianieri G., Megna G., Lancioni G., SAGGINI, Raoul, Ranieri M., Cristella G., Megna M.   +7 more
openaire   +3 more sources

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis

Frontiers in Microbiology, 2022
Botulinum neurotoxin (BoNT) is one of the most dangerous bacterial toxins and a potential biological weapon component. BoNT mechanism of pathological action is based on inhibiting the release of neurotransmitters from nerve endings.
Artem A. Derkaev, Ekaterina I. Ryabova, Ilias B. Esmagambetov, Dmitry V. Shcheblyakov, Svetlana A. Godakova, Irina D. Vinogradova, Anatoly N. Noskov, Denis Y. Logunov, Boris S. Naroditsky, Alexander L. Gintsburg   +9 more
doaj   +1 more source

Treating the face of women with botulinum toxin type A: 7-year review [PDF]

Revista Brasileira de Cirurgia Plástica, 2023
Introduction: Botulinum toxin type A (BTX-A) is the number one aesthetic procedure worldwide, and the difficulty in standardizing the aesthetic treatment of the face results in a broad range of treatment possibilities.
Victor Hugo Lara Cardoso Sá, Pablo Eduardo Elias, Gerson Vilhena Pereira, Ethel Zimberg Chehter   +3 more
doaj   +1 more source

Preoperative botulinum toxin type A: A case report of a proposed new strategy for giant hiatal hernia management

Clinical Case Reports, 2020
The use of preoperative ventral botulinum toxin for giant hiatal hernia management.
Francisco Tustumi, Edno Tales Bianchi, Sérgio Szachnowicz, Rider May Cedro, Antonio Afonso deMiranda Neto, André Luiz Gioia Morrell, Ricardo Zugaib Abdalla, Rubens Antonio Aissar Sallum, Ivan Cecconello   +8 more
doaj   +1 more source

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome [PDF]

International Neurourology Journal, 2015
Intravesical onabotulinumtoxinA (BoNT-A) injection is an effective treatment for overactive bladder syndrome (OAB) that is refractory to antimuscarinics.
Chun-Hou Liao, Hann-Chorng Kuo
doaj   +1 more source

Botulinum toxin a in the treatment of blepharospasm - A 10-year experience [PDF]

, 2005
To evaluate the long-term effect of botulinum toxin type A (BTX) in the treatment of blepharospasm, a retrospective analysis was conducted from the patients seen at the Movement Disorders Clinic of the Department of Neurology, Hospital das Clinicas ...
Goncalves, LR, Chien, HF, Silveira-Moriyama, L, Lilian R. Gonçalves, Laura Silveira-Moriyama, Barbosa, ER, Egberto R. Barbosa, Hsin Fen Chien   +7 more
core   +1 more source

Botulinum Neurotoxins (BoNTs) and Their Biological, Pharmacological, and Toxicological Issues: A Scoping Review

Applied Sciences, 2021
Botulinum toxins or neurotoxins (BoNTs) are the most potent neurotoxins known, and are currently extensively studied, not only for their potential lethality, but also for their possible therapeutic and cosmetic uses.
Massimo Corsalini, Francesco Inchingolo, Gianna Dipalma, Angelika Elzbieta Wegierska, Ioannis Alexandros Charitos, Maria Assunta Potenza, Antonio Scarano, Felice Lorusso, Alessio Danilo Inchingolo, Monica Montagnani, Luigi Santacroce   +10 more
doaj   +1 more source

Botulinum toxin type A for the management of glabellar rhytids [PDF]

, 2010
Anne Marie Tremaine, Jerry L McCulloughDepartment of Dermatology, University of California, Irvine, CA, USAAbstract: There is an increasing demand for minimally-invasive cosmetic procedures to arrest the aging process.
Tremaine, Anne Marie, Anne Marie Tremaine, McCullough, Jerry L, Jerry L McCullough   +3 more
core   +1 more source

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials

Toxins, 2023
DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A product containing daxibotulinumtoxinA with a stabilizing excipient peptide (RTP004).
Conor J. Gallagher, Ronald R. Bowsher, Amanda Clancy, Jeffrey S. Dover, Shannon Humphrey, Yan Liu, Gregg Prawdzik   +6 more
doaj   +1 more source

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis [PDF]

Investigative and Clinical Urology, 2020
After decades of clinical and basic science research, the clinical application of botulinum toxin A (Botox) in urology has been extended to neurogenic detrusor overactivity (NDO), idiopathic detrusor overactivity, refractory overactive bladder (OAB ...
Jing-Liang Chen , Hann-Chorng Kuo
doaj   +1 more source